All Type of News
KFDA considers foreign on-spot inspection
The Korea Food and Drug Administration plans to dispatch an on-site inspection team at the end of this month to Merck and Company of the United States as part of expanding its new GMP related inspection to new drugs.
...
Sprycel price adjustment plan draws strong protest
The government plan to adjust the insurance price of BMS Korea's Sprycel (dasatinib), an oral inhibitor of multiple tyrosine kinases, is drawing from leukemia patients, according to the Ministry of Health, Welfare and...
Government urged to ease cGMP regulations
The government needs to ease the current Good Manufacturing Practice (cGMP) system, while delaying the implementation period and defining the roadmap of quality control in more detail, according to the Korea Pharmaceu...
Pharmaceutical industry will face stronger headwinds
The combined sales of the 80 domestic pharmaceutical manufacturing firms last year marked a growth rate of 13 percent from 2007. Many say the pharmaceutical industry is in good shape and will fare well going forward, ...
Novartis Korea makes braille name cards for AMD patientsEmployees in ophthalmic unit of Novartis Korea are using braille name cards for patients with age-related macular degeneration (AMD).
Braille names cards give immediate infor...
|
11 healthcare providers elected to parliament
A total of 11 healthcare providers, including four doctors and three pharmacists, were elected in April 9 to the National Assembly.
One male pharmacist from the ruling Grand National Party (GNP), Won Hee-mok, the i...
10 multinationals spent 36.9 billion won as last year’s entertainment expenses
The combined entertainment expenses of the ten foreign-invested pharmaceutical firms were
36.9 billion won last year,
according to a report by the Financial Supervisory Service.
Aventis Pharma toppe...
KFDA discloses GMP ratings of 1,613 medicines
The Korea Food and Drug Administration has recently announced that a total of 1,613 items were evaluated in 2007 for their GMP ratings.
The GMP evaluation results showed that overall, the higher GMP level was impro...
Wholesalers threaten to boycott GSK products
The Pharmaceutical Development Consultative Committee decided to boycott all prescription drugs of GlaxoSmithKline on April 9, threatening to return all of GSK products.
The PDCC asked, via its mail, GSK to restore...
Lilly willing to cooperate with Korean scientists over MDR-TB programs
Eli Lilly, a U.S.-based pharmaceutical company, plans to expand its research programs to fight multidrug-resistant tuberculosis (MDR-TB) with Korean scientists.
“We have talked with Korea’s research institutes incl...
